Astrazeneca (AZN) Cash from Operations (2009 - 2026)
Astrazeneca's Cash from Operations was $4.58 billion in Q2 2026, down 4.1% from $4.77 billion a year earlier but up 5.8% from the prior quarter.
Astrazeneca (AZN) Cash from Operations (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's Cash from Operations was $18.37 billion through Jun 30, 2026, up 3.8% year-over-year; for FY2025, it came in at $18.74 billion, up 17.7% from FY2024.
- Cash from Operations has now increased for seven consecutive years, with a five-year compound annual growth rate of 21.4% (FY2020 to FY2025).
- In earlier years, Cash from Operations was $15.92 billion in FY2024 (+15.5%), $13.79 billion in FY2023 (+12.3%), $12.28 billion in FY2022 (+45.7%) and $8.43 billion in FY2021 (+18.8%).
- Quarterly Cash from Operations has moved between $2.16 billion (Q4 2021) and $6.22 billion (Q3 2025) over five years.
- Compared with a year earlier, Cash from Operations has declined for three straight quarters, with growth averaging 10.6% over the last six quarters.
- The best year-over-year quarter for Cash from Operations over five years was Q2 2024 (growth of 52.3%); the worst was Q4 2025 (a decline of 17.3%).
- Per Business Quant data, AZN's Cash from Operations in the three quarters before Q2 2026 was $4.33 billion (Q1 2026), $3.24 billion (Q4 2025) and $6.22 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.62 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.58 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.13 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.58 Bn |
| Mar 31, 2026 | 4.33 Bn |
| Dec 31, 2025 | 3.24 Bn |
| Sep 30, 2025 | 6.22 Bn |
| Jun 30, 2025 | 4.77 Bn |
| Mar 31, 2025 | 4.50 Bn |
| Dec 31, 2024 | 3.92 Bn |
| Sep 30, 2024 | 4.52 Bn |
| Jun 30, 2024 | 4.23 Bn |
| Mar 31, 2024 | 3.26 Bn |
| Jun 30, 2023 | 2.78 Bn |
| Mar 31, 2023 | 3.62 Bn |
| Jun 30, 2022 | 2.22 Bn |
| Mar 31, 2022 | 3.65 Bn |
| Dec 31, 2021 | 2.16 Bn |
| Sep 30, 2021 | 2.25 Bn |
| Jun 30, 2021 | 1.57 Bn |
| Mar 31, 2021 | 2.45 Bn |
| Dec 31, 2020 | 2.36 Bn |
| Sep 30, 2020 | 2.43 Bn |
Astrazeneca Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();